Korea University Anam Hospital
anam.kumc.or.krLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
110
Active
32
Phase 3
7
Total enrollment
38,445
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combination therapy | — | — | — | — | — | 2 | |
| Nicorandil | — | — | — | — | — | 1 | |
| Enavogliflozin | — | — | — | — | — | 1 | |
| statins, ezetimibe | — | — | — | — | — | 1 | |
| Rivaroxaban 20 MG | — | — | — | — | — | 1 | |
| Rivaroxaban 15 MG | — | — | — | — | — | 1 | |
| High intensity statin monotherapy | — | — | — | — | — | 1 | |
| Niraparib | — | — | — | — | — | 1 | |
| Fruquintinib | — | — | — | — | — | 1 | |
| Nelmastobart and Capecitabine | — | — | — | — | — | 1 | |
| Injection allogenic Umbilical Cord-derived Mesenchymal Stem Cell | — | — | — | — | — | 1 | |
| Ezetimibe/fenofibrate (Ezefeno) and moderate-intensity statin | — | — | — | — | — | 1 | |
| Dose escalation of moderate-intensity statin | — | — | — | — | — | 1 |
Next readouts
- 2025-12-01
- 2025-12-31
- 2026-04
- 2026-06-30
- 2026-06-30
- 2026-07
- 2027-02-01
- 2027-03-01
- 2028-01-25
- 2029-08-31
Top conditions
- Coronary Artery Disease7
- Hypertension5
- Diabetes Mellitus4
- Diabetes Mellitus, Type 24
- Colorectal Cancer4
- Colon Adenoma3
- Persistent Atrial Fibrillation3
- Gastric Cancer3
Frequently asked questions about Korea University Anam Hospital
- How many clinical trials does Korea University Anam Hospital have on ClinicalTrials.gov?
- Korea University Anam Hospital is listed as the lead sponsor on 110 clinical trials in ClinicalTrials.gov, 32 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Korea University Anam Hospital's trials are in Phase 3?
- 7 of Korea University Anam Hospital's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Korea University Anam Hospital focus on?
- Korea University Anam Hospital's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Hypertension, Diabetes Mellitus, Diabetes Mellitus, Type 2, Colorectal Cancer.
- When are Korea University Anam Hospital's next clinical trial readouts?
- Korea University Anam Hospital has 10 upcoming primary-completion readouts tracked here; the soonest is “Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer”, expected around 2025-12-01.